Anal Cancer Examination (ACE) Study - Annual Anal Examinations To Detect Early Anal Cancer In HIV Positive Men Who Have Sex With Men
Funder
National Health and Medical Research Council
Funding Amount
$60,926.00
Summary
Anal cancer is the most frequently occurring (non-AIDS defining) cancer in HIV positive men who have sex with men. There are still no guidelines for how to screen for this cancer. This research aims to determine the feasibility of implementing an annual anal examination to detect early anal cancer in HIV positive men who have sex with men.
Randomized Controlled Trial Of A Video-delivered Intervention For The Early Detection Of Melanoma In Men 50+ Years
Funder
National Health and Medical Research Council
Funding Amount
$511,694.00
Summary
Unfortunately, men over 50 years are most at risk to die from melanoma. Skin self-examination, where a man inspects the skin of his whole body with the help of a mirror or another person, and rapid presentation to a doctor without delay if he detects a suspicious lesion has the potential to increase awareness for the skin and to improve early diagnosis. We want to assess if we can increase the rate of skin self-examination in men 50 years and over through a video-delivered intervention.
Integrating Behaviour Change And Technology Uptake Models Into Skin Cancer Prevention And Early Detection
Funder
National Health and Medical Research Council
Funding Amount
$459,271.00
Summary
Two in three Australians will develop skin cancer in their lifetime, and skin cancer incidence is expected to increase. Therefore optimal ways to prevent and early detect skin cancers are of utmost importance to Australia’s public. By integrating the latest behaviour change models and technology uptake models to develop innovative interventions, this fellowship aims to ascertain that all Australians regardless of their location have access to optimal skin cancer prevention and early detection ca ....Two in three Australians will develop skin cancer in their lifetime, and skin cancer incidence is expected to increase. Therefore optimal ways to prevent and early detect skin cancers are of utmost importance to Australia’s public. By integrating the latest behaviour change models and technology uptake models to develop innovative interventions, this fellowship aims to ascertain that all Australians regardless of their location have access to optimal skin cancer prevention and early detection care.Read moreRead less
A Program Of Research In Behavioural Oncology: On The Interface Between Behavioural Research And Cancer Control
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Health behaviours are very important in the early detection of cancer, and they often determine whether a cancer patient will have a good quality of life after cancer treatment. The proposed research program aims to increase our understanding of how to improve health behaviours in order to be able to diagnose cancer as early as possible, and to develop interventions that will help patients to have the best possible care after cancer treatment.
Effectiveness And Cost-effectiveness Of Systematic Screening For Lynch Syndrome (LS) In Australia
Funder
National Health and Medical Research Council
Funding Amount
$485,762.00
Summary
Lynch syndrome (LS) is an inherited condition that puts people at an increased risk of developing a range of cancers. We will use a detailed simulation model to evaluate the potential health benefits of testing new cases of colorectal, endometrial and ovarian cancers for LS, and whether this would be cost-effective. The aim is to identify LS-related cancer cases, so family members can be offered LS testing, and individuals found to have LS can be offered close observation/preventative surgery.
Breast CAncer STratification: Understanding The Determinants Of Risk And Prognosis Of Molecular Subtypes
Funder
National Health and Medical Research Council
Funding Amount
$472,984.00
Summary
Breast cancer is not one disease, but many different types with different causes, treatments and outcomes. The aim of this project is to use genetic, lifestyle/environmental, mammographic breast density, pathologic and clinical data froma very large number of studies from all over the world to develop ways of predicting which women are at risk of particuar types of breast cancer, and if breast cancer develops what the likely outcome will be.
A Pragmatic Randomised Clinical Trial Of Nicotine Vaporisers Added To Smoking Cessation Treatment For Priority Populations Living With Comorbidities
Funder
National Health and Medical Research Council
Funding Amount
$1,499,145.00
Summary
Smoking is a leading cause of early death for people with certain health conditions because they are more likely to smoke and are also at greater risk of tobacco-related disease. This clinical trial will test whether encouraging people living with Hepatitis C Virus, people on opiate substitution therapy and people living with HIV who smoke to use nicotine vaporisers long-term, in addition to current smoking cessation treatments, will help them to stay abstinent from smoking.
Validation Of The Acceptability And Reliability Of Anal Swabs Used For Cytological Screening Among HIV+ MSM
Funder
National Health and Medical Research Council
Funding Amount
$76,108.00
Summary
This study will be screening HIV-positive men who have sex with men for Anal Squamous Intra-epithelial Lesions.These lesions, if left untreated, could develop into anal cancer. The study will take anal cytology swabs from 1000 HIV-positive men who attend the HIV clinic at St Vincent's hospital. Those men who are identified as having high-grade lesions (HSIL) or atypical cells (ASCUS) will be offered follow up by the principal investigator, Dr Richard Hillman.
Re-participation In Screening For Colorectal Cancer: Behavioural Outcomes And Predictors.
Funder
National Health and Medical Research Council
Funding Amount
$687,438.00
Summary
Screening for bowel cancer (CRC) is an important public health initiative. It is most effective when undertaken regularly but there is little research on what personal factors relate to ongoing participation in a screening program. This study will determine the factors associated with ongoing participation in CRC screening and will lead to better screening programs and improved health benefits. This study directly addresses the Cancer Australia priority area re improving screening programs.
Assessment Of The Effects Of Pathogenic Germline TP53 Mutations; International Sarcoma Kindred Study Participants’ Views Of Feedback Of Genetic Research Results And The Acceptability Of Taking Part In A Pilot Screening Programme
Funder
National Health and Medical Research Council
Funding Amount
$55,242.00
Summary
The International Sarcoma Kindred Study (ISKS) aims to identify individuals who harbour germline TP53 mutations. TP53 mutations are characterised by the development of multiple cancers including sarcoma. This project will assess ISKS participants’ views of the feedback of genetic research information and will develop sensitive feedback practices. The acceptability and psychological impact of taking part in a pilot screening protocol designed for cancer-prone populations will also be assessed.